deltatrials
Completed OBSERVATIONAL NCT02485275

Stroke Imaging Package Study (SIPS)

Sponsor: Army Medical Center of PLA

Updated 14 times since 2017 Last updated: Dec 12, 2018 Started: Jul 1, 2015 Primary completion: Apr 30, 2017 Completion: Nov 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Ischemic Stroke and Cerebral Small Vessel Diseases and is currently completed. Army Medical Center of PLA leads this study, which shows 14 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Study Description(click to expand)

1. Patients with acute ischemic stroke within 4.5-72h after onset were prospectively enrolled in our study and underwent standardized clinical and new imaging technique package assessment. 2. New imaging technique package mainly includes conventional cranial MRI (T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), and intracranial vessel wall imaging (High-Resolution Magnetic Resonance Imaging,HRMRI) as well as susceptibility weighted imaging (SWI). 3. The neurofunctional fluctuation during hospitalization as well as 90-day outcomes were carefully assessed. Patients were followed up for 90-days after stroke onset. 4. Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

1. Patients with acute ischemic stroke within 4.5-72h after onset were prospectively enrolled in our study and underwent standardized clinical and new imaging technique package assessment. 2. New imaging technique package mainly includes conventional cranial MRI (T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), and intracranial vessel wall imaging (High-Resolution Magnetic Resonance Imaging,HRMRI) as well as susceptibility weighted imaging (SWI). 3. The neurofunctional fluctuation during hospitalization as well as 90-day outcomes were carefully assessed. Patients were followed up for 90-days after stroke onset. 4. Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Oct 2017 · 4 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshot

Change History

14 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Oct 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Oct 2021 [monthly]

    Completed

  5. Jan 2019 — Jan 2021 [monthly]

    Completed

Show 9 earlier versions
  1. Aug 2018 — Jan 2019 [monthly]

    Completed

  2. Jul 2018 — Aug 2018 [monthly]

    Completed

  3. Jun 2018 — Jul 2018 [monthly]

    Completed

  4. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  5. Dec 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  6. Oct 2017 — Dec 2017 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  7. Jun 2017 — Oct 2017 [monthly]

    Recruiting NA

  8. May 2017 — Jun 2017 [monthly]

    Recruiting NA

  9. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Army Medical Center of PLA
  • Beijing Jishuitan Hospital
  • China-Japan Union Hospital, Jilin University
  • Fujian Medical University Union Hospital
  • Peking Union Medical College Hospital
  • Qilu Hospital of Shandong University
  • Renmin Hospital of Wuhan University
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Shanghai Tong Ren Hospital
  • Subei People's Hospital of Jiangsu Province
  • Tangshan Gongren Hospital
  • The First Affiliated Hospital of University of South China
  • The First Hospital of Jilin University
  • The General Hospital of Northern Theater Command
  • The Third Medical Center of Chinese PLA General Hospital
  • Third Affiliated Hospital, Sun Yat-Sen University
  • Wei-Hai Xu
Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .